These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors. Arbit E; Cheung NK; Yeh SD; Daghighian F; Zhang JJ; Cordon-Cardo C; Pentlow K; Canete A; Finn R; Larson SM Eur J Nucl Med; 1995 May; 22(5):419-26. PubMed ID: 7641750 [TBL] [Abstract][Full Text] [Related]
10. Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8. Kramer K; Humm JL; Souweidane MM; Zanzonico PB; Dunkel IJ; Gerald WL; Khakoo Y; Yeh SD; Yeung HW; Finn RD; Wolden SL; Larson SM; Cheung NK J Clin Oncol; 2007 Dec; 25(34):5465-70. PubMed ID: 18048828 [TBL] [Abstract][Full Text] [Related]
11. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts. Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078 [TBL] [Abstract][Full Text] [Related]
12. Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2. Miederer M; McDevitt MR; Borchardt P; Bergman I; Kramer K; Cheung NK; Scheinberg DA Clin Cancer Res; 2004 Oct; 10(20):6985-92. PubMed ID: 15501978 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts. Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):813-23. PubMed ID: 9240651 [TBL] [Abstract][Full Text] [Related]
14. Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model. Ugur O; Scott AM; Kostakoglu L; Hui TE; Masterson ME; Febo R; Sgouros G; Rosa E; Mehta BM; Fisher DR Nucl Med Biol; 1995 Jan; 22(1):87-93. PubMed ID: 7735175 [TBL] [Abstract][Full Text] [Related]
15. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments. Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348 [TBL] [Abstract][Full Text] [Related]
16. Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8. Bergman I; Arbit E; Rosenblum M; Larson SM; Heller G; Cheung NK J Neurooncol; 1993 Mar; 15(3):235-42. PubMed ID: 8360709 [TBL] [Abstract][Full Text] [Related]
17. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody. Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007 [TBL] [Abstract][Full Text] [Related]
18. SPECT imaging of colorectal cancer by targeting CD 133 receptor with 99mTc-labeled monoclonal antibody. Liu Y; Jin X; Lan X; Lang J; Wen Q; An R Q J Nucl Med Mol Imaging; 2019 Jun; 63(2):216-224. PubMed ID: 27387378 [TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758 [TBL] [Abstract][Full Text] [Related]
20. Preparation of hydrazino-modified proteins and their use for the synthesis of 99mTc-protein conjugates. Schwartz DA; Abrams MJ; Hauser MM; Gaul FE; Larsen SK; Rauh D; Zubieta JA Bioconjug Chem; 1991; 2(5):333-6. PubMed ID: 1838699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]